Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$0

Avg closing price
Price range

2 Paul Tudor Jones II Evommune Trades

Paul Tudor Jones II started to build up the position in Evommune in Q4 2025. Since then they sold 32k shares. The investor sold all their shares in Q1 2026 and doesn't own any shares in Evommune anymore.

Avg closing price
Price range
Sold -32k shares Q1 2026
Avg closing price $24.86
Price range $21.02 - $31.10
New holding (+32k shares) Q4 2025
Avg closing price -
Price range - - -

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!